Showing results (281-290 of 293) with videos related to
Sort By:
Pageof 30
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.The American Journal of Clinical Nutrition|August 1, 1997
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected dietJ A Metz, P M Kris-Etherton, C D Morris, et al.Diabetes Care|May 20, 1999
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetesF X Pi-Sunyer, C A Maggio, D A McCarron, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study GroupD M Green, N E Breslow, J B Beckwith, et al.Medical and Pediatric Oncology|February 25, 1998
Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group studyC B Pratt, H M Maurer, P Gieser, et al.AJNR. American Journal of Neuroradiology|February 25, 2022
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, A Ziaei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study GroupD M Green, N E Breslow, J B Beckwith, et al.The American Journal of Clinical Nutrition|October 28, 1999
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular diseaseA Chait, M R Malinow, D N Nevin, et al.Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiationP R Thomas, M Deutsch, J L Kepner, et al.Pageof 30